Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity
Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 11, pp. 1405-1413
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
Ayelet Grupper, Liane Rabinowich, Doron Schwartz, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2719-2726
Open Access | Times Cited: 357
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
Liane Rabinowich, Ayelet Grupper, Roni Baruch, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 435-438
Open Access | Times Cited: 321
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
Frauke Muecksch, Helen Wise, Becky Batchelor, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 3, pp. 389-398
Open Access | Times Cited: 276
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine
Mikiko Watanabe, Angela Balena, Dario Tuccinardi, et al.
Diabetes/Metabolism Research and Reviews (2021) Vol. 38, Iss. 1
Open Access | Times Cited: 263
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1345-1350
Closed Access | Times Cited: 232
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
Anne J. Jääskeläinen, Suvi Kuivanen, Eliisa Kekäläinen, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104512-104512
Open Access | Times Cited: 199
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel, Evan M. Bloch, William Clarke, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 191
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 177
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench, Simon Jochum, Verena Wenderoth, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 10
Open Access | Times Cited: 168
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Ohad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 625-634
Open Access | Times Cited: 95
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel, Yotam Shenhar, Ilan Green, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 95
Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations
Bernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 751-765
Open Access | Times Cited: 90
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 1042-1042
Open Access | Times Cited: 77
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
Frauke Muecksch, Helen Wise, Becky Batchelor, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 76
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals
Haleema Alserehi, Ada Alqunaibet, Jaffar A. Al‐Tawfiq, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 3, pp. 115273-115273
Open Access | Times Cited: 74
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander Egger, Wolfgang Prokop, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 8, pp. 1453-1462
Open Access | Times Cited: 65
The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects
Chiara Di Resta, Davide Ferrari, Marco Viganò, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 522-522
Open Access | Times Cited: 64
Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms
Sarah E. Turbett, Melis N. Anahtar, Anand S. Dighe, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 1
Open Access | Times Cited: 61
Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination
Krzysztof Łukaszuk, Jolanta Kiewisz, Karolina Rozanska, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 840-840
Open Access | Times Cited: 41
B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek, Fritz Leutmezer, Paulus Rommer, et al.
Annals of Neurology (2022) Vol. 91, Iss. 3, pp. 342-352
Open Access | Times Cited: 36
Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine
Mikiko Watanabe, Angela Balena, Davide Masi, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 79-79
Open Access | Times Cited: 34
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2482-2501
Open Access | Times Cited: 7
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
Shey‐Ying Chen, Yu-Lin Lee, Yi‐Chun Lin, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2157-2168
Open Access | Times Cited: 43
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
Salma Younes, Hadeel Al-Jighefee, Farah M. Shurrab, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 245-245
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top